Lenard M. Lichtenberger

Keywords Blood Platelets, COVID-19, Humans, Inflammation, Neoplasms, Platelet Activation, Risk Assessment, Risk Factors, SARS-CoV-2, Thrombosis Abstract Patients with cancer are more susceptible to be infected by SARS-CoV-2 and develop severe outcomes including ICU admittance, mechanical ventilator support, and a high rate of mortality. Like mid-to late-stage cancer, SARS-CoV-2 infection is associated with platelet hyperactivity, systemic inflammation, thrombotic complications, and coagulopathy.

Controversy and Consensus Lenard M. Lichtenberger and K. Vinod Vijayan DOI: 10.1158/0008-5472.CAN-20-3691 Published March 2021 Abstract Patients with cancer are more susceptible to be infected by SARS-CoV-2 and develop severe outcomes including ICU admittance, mechanical ventilator support, and a high rate of mortality. Like mid-to late-stage cancer, SARS-CoV-2 infection is associated with platelet hyperactivity, systemic inflammation, thrombotic complications, and coagulopathy.